top of page

News

Incubate Bio announces new discovery pipeline of 70 potential oncology combination therapies, November 23 2023

Click Here to Learn More

Identification of Dasatinib as a potential combination therapy for AZD6738 in ovarian cancer, November 6 2023

Click Here to Learn More

QV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma, October 24 2023

Click Here to Learn More

Launching service to address biotech’s #1 pain point – DATA FOR FUNDRAISING, October 12 2023

Click Here to Learn More

Cost-efficient expansion of key biological data to enhance the validation and value of therapeutic investment propositions, September 20 2023

Click Here to Download

Boosting biotech valuations with cost-efficient addition of key in silico evidence, September 8 2023

Click Here to Read

In silico discovery and overcoming bias with AI, August 13 2023

Click Here to Read

Incubate Bio solidifies its computational leadership position with latest appointment, August 11 2023

Click Here to Download

ALaSCAdb: Incubate Bio open sources characterized targets database for drug sensitivity and target discovery in Ovarian cancer, July 19 2023

Click Here to Download

Jiva.ai and Incubate Bio enter a Strategic Collaboration to Advance Personalized Medicine, April 3 2023

Click Here to Download

QV Bioelectronics and Incubate Bio enter a Strategic Collaboration to Accelerate the Treatment of Glioblastoma, March 27 2023

Click Here to Download

bottom of page